MedPath

Guideline-based antibiotics therapy versus empirical therapy for nursing and healthcare-associated pneumonia: A randomized controlled trial

Not Applicable
Conditions
ursing and healthcare-associated pneumonia
Registration Number
JPRN-UMIN000006792
Lead Sponsor
Department of Respiratory Medicine, Hamamatsu Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Known severe allergy to any drugs. (2) Patients receiving broad-spectrum antibiotics before admission. (3) Fatal and severe underlying disease, malignancy, COPD, heart failure and so on. (4) Patients who cannot safely receive cessation of eating or hydration as a treatment for pneumonia because of dementia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In-hospital mortality and relapses of pneumonia occurring within 30 days following admission.
Secondary Outcome Measures
NameTimeMethod
Initial choice of antibiotics, the number of drug-change and duration of therapy. Adverse effects from antibiotics therapy. Cost of medical care for pneumonia.
© Copyright 2025. All Rights Reserved by MedPath